Literature DB >> 28208140

First Diagnosis of Atrial Fibrillation at the Time of Stroke.

Leila H Borowsky1, Susan Regan, Yuchiao Chang, Alison Ayres, Steven M Greenberg, Daniel E Singer.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is a major cause of ischemic stroke. Individuals with undiagnosed AF lack the stroke protection afforded by oral anticoagulants. We obtained a contemporary estimate of the percentage of AF patients newly diagnosed at the time of stroke.
METHODS: We identified patients admitted to the Massachusetts General Hospital (MGH) from January 1, 2010 to December 31, 2013 with acute ischemic stroke and either previously or newly diagnosed AF using hospital stroke registry data and stroke and AF ICD-9 code searches of hospital databases. Reviewers categorized AF as previously known or newly diagnosed, and collected comorbidity and outcome data. To confirm AF as newly diagnosed, we searched patients' pre-event electronic medical records (EMRs) for AF terms.
RESULTS: AF was considered newly diagnosed in 156/856 patients (18%; 95% CI 16-21). In 136/156 cases, AF was diagnosed using 12-lead EKG, telemetry, or rhythm strips. New AF strokes had a median NIH stroke scale of 12; 60% had mRankin ≥3 at discharge, including 15% deaths. Pre-stroke CHA2DS2-VASc score was ≥2 in 89%. About half (76/156) had prior records in the MGH EMR. Evidence of pre-stroke AF, often peri-procedural, was found in 8/76, but the AF diagnosis was not carried forward.
CONCLUSIONS: In this contemporary cohort, nearly one in 5 AF-related strokes occurred without a pre-stroke AF diagnosis. AF was readily diagnosed using standard rhythm monitoring. The vast majority of patients with newly diagnosed AF were at high enough pre-stroke risk to merit anticoagulation. In conclusion, our findings support screening for AF before stroke. Patients with past transient AF may merit more intensive screening.
© 2017 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28208140     DOI: 10.1159/000457809

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  13 in total

1.  Using mobile ECG devices to increase detection of atrial fibrillation across a range of settings in south London.

Authors:  Alex Lang; Faye Edwards; Dominic Norton; Laura Semple; Helen Williams
Journal:  Future Healthc J       Date:  2020-02

2.  Design and rationale of a pragmatic trial integrating routine screening for atrial fibrillation at primary care visits: The VITAL-AF trial.

Authors:  Jeffrey M Ashburner; Steven J Atlas; David D McManus; Yuchiao Chang; Ana T Trisini Lipsanopoulos; Leila H Borowsky; Wyliena Guan; Wei He; Patrick T Ellinor; Daniel E Singer; Steven A Lubitz
Journal:  Am Heart J       Date:  2019-06-22       Impact factor: 4.749

3.  Initial Precipitants and Recurrence of Atrial Fibrillation.

Authors:  Elizabeth Y Wang; Olivia L Hulme; Shaan Khurshid; Lu-Chen Weng; Seung Hoan Choi; Allan J Walkey; Jeffrey M Ashburner; David D McManus; Daniel E Singer; Steven J Atlas; Emelia J Benjamin; Patrick T Ellinor; Ludovic Trinquart; Steven A Lubitz
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-02-12

4.  Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: VITAL-AF Randomized Controlled Trial.

Authors:  Steven A Lubitz; Steven J Atlas; Jeffrey M Ashburner; Ana T Trisini Lipsanopoulos; Leila H Borowsky; Wyliena Guan; Shaan Khurshid; Patrick T Ellinor; Yuchiao Chang; David D McManus; Daniel E Singer
Journal:  Circulation       Date:  2022-03-02       Impact factor: 29.690

5.  Contact-Free Screening of Atrial Fibrillation by a Smartphone Using Facial Pulsatile Photoplethysmographic Signals.

Authors:  Bryan P Yan; William H S Lai; Christy K Y Chan; Stephen Chun-Hin Chan; Lok-Hei Chan; Ka-Ming Lam; Ho-Wang Lau; Chak-Ming Ng; Lok-Yin Tai; Kin-Wai Yip; Olivia T L To; Ben Freedman; Yukkee C Poh; Ming-Zher Poh
Journal:  J Am Heart Assoc       Date:  2018-04-05       Impact factor: 5.501

6.  First approach to distinguish between cardiac and arteriosclerotic emboli of individual stroke patients applying the histological THROMBEX-classification rule.

Authors:  Florian C Roessler; Nicolas Kalms; Florian Jann; Andrè Kemmling; Julika Ribbat-Idel; Florian Stellmacher; Inke R König; Marcus Ohlrich; Georg Royl
Journal:  Sci Rep       Date:  2021-04-19       Impact factor: 4.379

7.  Racial and Urban-Rural Difference in the Frequency of Ischemic Stroke as Initial Manifestation of Atrial Fibrillation.

Authors:  Jingchuan Guo; Nico Gabriel; Jared W Magnani; Utibe R Essien; Walid F Gellad; Maria M Brooks; Ludovic Trinquart; Emelia J Benjamin; Inmaculada Hernandez
Journal:  Front Public Health       Date:  2021-11-05

8.  Electronic physician notifications to improve guideline-based anticoagulation in atrial fibrillation: a randomized controlled trial.

Authors:  Jeffrey M Ashburner; Steven J Atlas; Shaan Khurshid; Lu-Chen Weng; Olivia L Hulme; Yuchiao Chang; Daniel E Singer; Patrick T Ellinor; Steven A Lubitz
Journal:  J Gen Intern Med       Date:  2018-08-03       Impact factor: 6.473

Review 9.  ECG Monitoring Systems: Review, Architecture, Processes, and Key Challenges.

Authors:  Mohamed Adel Serhani; Hadeel T El Kassabi; Heba Ismail; Alramzana Nujum Navaz
Journal:  Sensors (Basel)       Date:  2020-03-24       Impact factor: 3.576

10.  Development and Validation of a Prediction Model for Atrial Fibrillation Using Electronic Health Records.

Authors:  Olivia L Hulme; Shaan Khurshid; Lu-Chen Weng; Christopher D Anderson; Elizabeth Y Wang; Jeffrey M Ashburner; Darae Ko; David D McManus; Emelia J Benjamin; Patrick T Ellinor; Ludovic Trinquart; Steven A Lubitz
Journal:  JACC Clin Electrophysiol       Date:  2019-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.